Elite Pharmaceuticals, Inc. Increase (Decrease) in Deferred Revenue
Elite Pharmaceuticals, Inc. (ELTP) reported Increase (Decrease) in Deferred Revenue of -$5.56 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was -$2.22K.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was -$3.33K.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2026 was -$5.56K.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2025 was -$13.33K.
- Elite Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2024 was -$13.33K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $0.00 derived: sum of 2 quarters · filed 2026-06-29 | -$2.22K derived: sum of 3 quarters · filed 2026-06-29 | -$5.56K 10-K · filed 2026-06-29 |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | -$2.22K derived: sum of 2 quarters · filed 2026-02-17 | -$5.56K 10-Q · filed 2026-02-17 | -$8.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$2.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | -$5.56K 10-Q · filed 2025-11-14 | -$8.89K derived: sum of 3 quarters · filed 2026-08-13 | -$12.22K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$3.33K 10-Q · filed 2026-08-13 | -$6.67K derived: sum of 2 quarters · filed 2026-08-13 | -$10.00K derived: sum of 3 quarters · filed 2026-08-13 | -$13.33K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$6.67K derived: sum of 2 quarters · filed 2026-06-29 | -$10.00K derived: sum of 3 quarters · filed 2026-06-29 | -$13.33K 10-K · filed 2026-06-29 |
| 2024-12-31 | -$3.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | -$6.67K derived: sum of 2 quarters · filed 2026-02-17 | -$10.00K 10-Q · filed 2026-02-17 | -$13.33K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | -$3.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | -$6.67K 10-Q · filed 2025-11-14 | -$10.00K derived: sum of 3 quarters · filed 2025-11-14 | -$13.33K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$3.33K 10-Q · filed 2025-08-14 | -$6.67K derived: sum of 2 quarters · filed 2025-08-14 | -$10.00K derived: sum of 3 quarters · filed 2025-08-14 | -$13.33K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | -$6.67K derived: sum of 2 quarters · filed 2025-06-30 | -$10.00K derived: sum of 3 quarters · filed 2025-06-30 | -$13.33K 10-K · filed 2025-06-30 |
| 2023-12-31 | -$3.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | -$6.67K derived: sum of 2 quarters · filed 2025-02-13 | -$10.00K 10-Q · filed 2025-02-13 | |
| 2023-09-30 | -$3.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | -$6.67K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$3.33K 10-Q · filed 2024-08-14 |